Literature DB >> 20383022

Crystallization and preliminary X-ray study of the D-altritol oligonucleotide GTGTACAC.

Margriet Ovaere1, Arthur Van Aerschot, Mikhail Abramov, Piet Herdewijn, Luc Van Meervelt.   

Abstract

In altritol nucleic acids (ANAs), the natural five-membered ribose ring of RNA is replaced by the six-membered D-altritol ring. ANAs are good candidates to act as siRNAs in the RNA-interference pathway. Crystals of the fully modified altritol self-complementary octamer GTGTACAC were grown by the hanging-drop vapour-diffusion technique at 289 K. Diffraction data were recorded on SLS beamline X06DA and processed to 3.0 A resolution. The crystals belonged to the hexagonal space group P6(1)22 or P6(5)22, with unit-cell parameters a = 25.05, c = 117.58 A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383022      PMCID: PMC2852344          DOI: 10.1107/S1744309110007050

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

Review 1.  Mechanisms of gene silencing by double-stranded RNA.

Authors:  Gunter Meister; Thomas Tuschl
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  siRNAs: applications in functional genomics and potential as therapeutics.

Authors:  Yair Dorsett; Thomas Tuschl
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

3.  Hexagonal crystal structure of the A-DNA octamer d(GTGTACAC) and its comparison with the tetragonal structure: correlated variations in helical parameters.

Authors:  S Jain; G Zon; M Sundaralingam
Journal:  Biochemistry       Date:  1991-04-09       Impact factor: 3.162

4.  Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf.

Authors:  Michael Fisher; Mikhail Abramov; Arthur Van Aerschot; Jef Rozenski; Vidula Dixit; Rudy L Juliano; Piet Herdewijn
Journal:  Eur J Pharmacol       Date:  2009-01-30       Impact factor: 4.432

5.  Crystal structure of double helical hexitol nucleic acids.

Authors:  Ruben Declercq; Arthur Van Aerschot; Randy J Read; Piet Herdewijn; Luc Van Meervelt
Journal:  J Am Chem Soc       Date:  2002-02-13       Impact factor: 15.419

6.  Base only binding of spermine in the deep groove of the A-DNA octamer d(GTGTACAC).

Authors:  S Jain; G Zon; M Sundaralingam
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

7.  Structure of the fully modified left-handed cyclohexene nucleic acid sequence GTGTACAC.

Authors:  Koen Robeyns; Piet Herdewijn; Luc Van Meervelt
Journal:  J Am Chem Soc       Date:  2008-01-17       Impact factor: 15.419

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity.

Authors:  Jesper B Bramsen; Maria B Laursen; Anne F Nielsen; Thomas B Hansen; Claus Bus; Niels Langkjaer; B Ravindra Babu; Torben Højland; Mikhail Abramov; Arthur Van Aerschot; Dalibor Odadzic; Romualdas Smicius; Jens Haas; Cordula Andree; Jharna Barman; Malgorzata Wenska; Puneet Srivastava; Chuanzheng Zhou; Dmytro Honcharenko; Simone Hess; Elke Müller; Georgii V Bobkov; Sergey N Mikhailov; Eugenio Fava; Thomas F Meyer; Jyoti Chattopadhyaya; Marino Zerial; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  How does hydroxyl introduction influence the double helical structure: the stabilization of an altritol nucleic acid:ribonucleic acid duplex.

Authors:  Margriet Ovaere; Jiri Sponer; Judit E Sponer; Piet Herdewijn; Luc Van Meervelt
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.